
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy (FPHAF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FPHAF · as of Jun 9, 2026
Key Statistics
Explore Faron Pharmaceuticals Oy Data
fphaf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
fphaf competitorsStock Performance
Full HistoryAbout Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical firm dedicated to drug discovery and development. The company is advancing a pipeline of proprietary drug candidates that harness immune …
what is faron pharmaceuticals oy · fphaf stock overview · faron pharmaceuticals oy company profile · who is faron pharmaceuticals oy ceo · fphaf OTC · faron pharmaceuticals oy headquarters · faron pharmaceuticals oy business segments
About Stock Overview & Key Data
Faron Pharmaceuticals Oy (FPHAF) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 28, 2020. As of the latest trading session, FPHAF stock price is $3.30, with a market capitalization of $209.5M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2024, Faron Pharmaceuticals Oy reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Faron Pharmaceuticals Oy (FPHAF) stock price is $3.30. The stock is traded on OTC under the ticker symbol FPHAF. The 52-week range is $3.30 – $3.30.